Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why BioCryst Pharmaceuticals Stock Is Sinking Today

TheMotleyFool

0 0

Why BioCryst Pharmaceuticals Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/721631/scientists-in-a-lab.jpg

Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) are sinking today, down by 17.1% as of 11:09 a.m. ET. The big decline came after the drugmaker announced its fourth-quarter and full-year 2022 results before the market opened.

BioCryst reported Q4 revenue of $79.5 million, up from $47.2 million in the prior-year period. This result topped the consensus revenue estimate of $75.6 million.

The company posted a net loss in the fourth quarter of $71.5 million, or $0.38 per share, based on generally accepted accounting principles (GAAP). It posted a net loss of $17.8 million, or $0.10 per share, in Q4 2021. BioCryst recorded a non-GAAP loss of $73.6 million, or $0.40 per share.

Source Fool.com

Like: 0

BCRX

Share